“…1) were selected and evaluated concerning their antimicrobial activity, i.e., muramyl dipeptide derivatives (1a-e), the retro-tuftsin derivatives (2a-c), and analogs of anthraquinones (3a-d). These compounds were previously published as potential immunomodulators by Dzierzbicka and others (Dzierzbicka et al, 2003b;Dzierzbicka et al, 2004;Dzierzbicka et al, 2005a;Dzierzbicka et al, 2005b;Dzierzbicka et al, 2006;Dzierzbicka et al, 2008;Dzierzbicka et al, 2012) and Wardowska and others (Wardowska et al, 2006;Wardowska et al, 2009). Their antimicrobial activities were tested against five bacterial strains from four species (S. aureus MRSA/MSSA, K. pneumoniae ESBL, P. aeruginosa, and E. coli), and their MIC values (and those of the reference antibiotics) are presented in Table 1.…”